A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial

Article

Abstract: Background: There is evidence of a relationship between epidermal growth factor (EGF) and tumor cell

Palabras claves:

cancer vaccine, Epidermal growth factor

Autores:

Catala M., González G., Gonzalez Y.S., Guillén-Nieto G.E., Hernández J.C., Lage Davila A., Marinello P., Mirabal V., Tania Crombet

Fuentes:

scopus